Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
6.50
-0.12 (-1.81%)
May 2, 2025, 4:00 PM EDT - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $136.73 million as of May 2, 2025. Its market cap has decreased by -52.09% in one year.
Market Cap
136.73M
Enterprise Value
42.01M
1-Year Change
-52.09%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $136.73M, an increase of 50.10%. That is a compound annual growth rate of 9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 136.73M | -22.49% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |